journal article·2020-04

Osteoclasts degrade fibrinogen scaffolds and induce mesenchymal stem/stromal osteogenic differentiation

Ana R. Almeida, Mafalda Bessa‐Gonçalves, Daniel M. Vasconcelos, Mário A. Barbosa, Susana G. Santos

Publisher page

Abstract

Abstract Fibrinogen (Fg) is a pro‐inflammatory protein with pro‐healing properties. Previous work showed that fibrinogen 3D scaffolds (Fg‐3D) promote bone regeneration, but the cellular players were not identified. Osteoclasts are bone resorbing cells that promote bone remodeling in close crosstalk with osteoblasts. Herein, the capacity of osteoclasts differentiated on Fg‐3D to degrade the scaffolds and promote osteoblast differentiation was evaluated in vitro. Fg‐3D scaffolds were prepared by freeze‐drying and osteoclasts were differentiated from primary human peripheral blood monocytes. Results obtained showed osteoclasts expressing the enzymes cathepsin K and tartrate resistant acid phosphatase colonizing Fg‐3D scaffolds. Osteoclasts were able to significantly degrade Fg‐3D, reducing the scaffold's area, and increasing D‐dimer concentration, a Fg degradation product, in their culture media. Osteoclast conditioned media from the first week of differentiation promoted significantly stronger human primary mesenchymal stem/stromal cell (MSC) osteogenic differentiation, evaluated by alkaline phosphatase activity. Moreover, week 1 osteoclast conditioned media promoted earlier MSC osteogenic differentiation, than chemical osteogenesis inductors. TGF‐β1 was found increased in osteoclast conditioned media from week 1, when compared to week 3 of differentiation. Taken together, our results suggest that osteoclasts are able to differentiate and degrade Fg‐3D, producing factors like TGF‐β1 that promote MSC osteogenic differentiation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Bone health and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

i3S ‐ Instituto de Investigação e Inovação em Saúde, Universidade do Porto Porto 4200‐135 Portugal

INEB ‐ Instituto de Engenharia Biomédica, Universidade do Porto Porto 4200‐135 Portugal

ICBAS ‐ Instituto Ciências Biomédicas Abel Salazar, Universidade do Porto Porto 4050‐313 Portugal

Funding

Fundação para a Ciência e a Tecnologia · European Regional Development Fund

References (75)

Show source-provided references
1. 10.1182/blood-2008-06-16584510.1182/blood-2008-06-165845 ↗
2. 10.1016/j.rdc.2018.03.00410.1016/j.rdc.2018.03.004 ↗
3. 10.1098/rsif.2011.035710.1098/rsif.2011.0357 ↗
4. 10.1002/jbm.a.3052210.1002/jbm.a.30522 ↗
5. 10.1016/j.tice.2017.09.00210.1016/j.tice.2017.09.002 ↗
6. 10.1016/S8756-3282(99)00082-410.1016/S8756-3282(99)00082-4 ↗
7. 10.1111/j.1365-2362.2012.02717.x10.1111/j.1365-2362.2012.02717.x ↗
8. 10.1002/path.95910.1002/path.959 ↗
9. 10.11138/ccmbm/2017.14.1.18610.11138/ccmbm/2017.14.1.186 ↗
10. 10.1007/s10856-014-5240-210.1007/s10856-014-5240-2 ↗
11. 10.1038/cdd.2015.16810.1038/cdd.2015.168 ↗
12. 10.1172/JCI7005010.1172/JCI70050 ↗
13. 10.1242/jcs.06303210.1242/jcs.063032 ↗
14. 10.1002/term.185110.1002/term.1851 ↗
15. 10.1002/term.17410.1002/term.174 ↗
16. 10.1089/ten.2006.12.94910.1089/ten.2006.12.949 ↗
17. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate‐resistant acid phosphatase. Modulation of osteoclast adhesion in vitro10.1016/S0021-9258(17)36541-9 ↗
18. 10.1016/j.bone.2007.09.04410.1016/j.bone.2007.09.044 ↗
19. 10.1016/0014-4827(85)90173-910.1016/0014-4827(85)90173-9 ↗
20. 10.22203/eCM.v019a1010.22203/eCM.v019a10 ↗
21. 10.1126/science.106740410.1126/science.1067404 ↗
22. 10.1016/j.bone.2012.06.00710.1016/j.bone.2012.06.007 ↗
23. 10.1007/s00223-013-9741-710.1007/s00223-013-9741-7 ↗
24. 10.1038/550S193a10.1038/550S193a ↗
25. 10.1002/jbm.a.3639910.1002/jbm.a.36399 ↗
26. 10.1016/j.biomaterials.2018.07.01710.1016/j.biomaterials.2018.07.017 ↗
27. 10.1111/j.1600-0757.2006.00161.x10.1111/j.1600-0757.2006.00161.x ↗
28. 10.1111/j.1365-2141.1985.tb07476.x10.1111/j.1365-2141.1985.tb07476.x ↗
29. 10.1160/TH07-01-003910.1160/TH07-01-0039 ↗
30. 10.1016/j.bone.2010.09.02910.1016/j.bone.2010.09.029 ↗
31. 10.1186/2045-3701-3-410.1186/2045-3701-3-4 ↗
32. 10.1126/science.110762710.1126/science.1107627 ↗
33. 10.1002/jcb.2240610.1002/jcb.22406 ↗
34. 10.1016/j.biocel.2016.08.03410.1016/j.biocel.2016.08.034 ↗
35. 10.1016/j.biomaterials.2018.06.02610.1016/j.biomaterials.2018.06.026 ↗
36. 10.1038/nbt105510.1038/nbt1055 ↗
37. 10.1089/ten.tea.2012.043910.1089/ten.tea.2012.0439 ↗
38. 10.1088/1748-605X/aaaf2910.1088/1748-605X/aaaf29 ↗
39. 10.1089/ten.tea.2011.003010.1089/ten.tea.2011.0030 ↗
40. 10.1002/jbmr.218710.1002/jbmr.2187 ↗
41. 10.1007/s12026-009-8093-x10.1007/s12026-009-8093-x ↗
42. 10.1016/j.actbio.2016.09.02910.1016/j.actbio.2016.09.029 ↗
43. 10.1016/0021-9150(92)90069-S10.1016/0021-9150(92)90069-S ↗
44. 10.1007/s10875-009-9316-610.1007/s10875-009-9316-6 ↗
45. 10.1016/j.actbio.2016.11.03410.1016/j.actbio.2016.11.034 ↗
46. 10.22203/eCM.v024a1010.22203/eCM.v024a10 ↗
47. 10.1016/j.biomaterials.2008.06.03010.1016/j.biomaterials.2008.06.030 ↗
48. 10.1073/pnas.080513310610.1073/pnas.0805133106 ↗
49. 10.1002/jbm.a.3092810.1002/jbm.a.30928 ↗
50. 10.1016/S0142-9612(99)00280-X10.1016/S0142-9612(99)00280-X ↗
51. 10.1166/jnn.2014.912710.1166/jnn.2014.9127 ↗
52. 10.4161/org.2330610.4161/org.23306 ↗
53. 10.22203/eCM.v034a1810.22203/eCM.v034a18 ↗
54. 10.1016/S0169-6009(08)80187-010.1016/S0169-6009(08)80187-0 ↗
55. 10.1002/mabi.20040002610.1002/mabi.200400026 ↗
56. 10.1016/j.actbio.2013.04.00810.1016/j.actbio.2013.04.008 ↗
57. 10.1016/j.biomaterials.2003.10.07910.1016/j.biomaterials.2003.10.079 ↗
58. 10.1002/jbm.b.3340910.1002/jbm.b.33409 ↗
59. 10.1371/journal.pone.009140610.1371/journal.pone.0091406 ↗
60. 10.1089/ten.tea.2012.037410.1089/ten.tea.2012.0374 ↗
61. 10.3390/jfb901001810.3390/jfb9010018 ↗
62. 10.1038/bonekey.2013.22910.1038/bonekey.2013.229 ↗
63. 10.1038/nri206210.1038/nri2062 ↗
64. 10.1038/nrrheum.2014.21910.1038/nrrheum.2014.219 ↗
65. 10.1038/nm.197910.1038/nm.1979 ↗
66. The foreign body Giant cell cannot resorb bone, but dissolves hydroxyapatite like osteoclasts10.1371/journal.pone.0139564 ↗
67. 10.1002/jbm.a.3643310.1002/jbm.a.36433 ↗
68. 10.1016/j.actbio.2013.01.01510.1016/j.actbio.2013.01.015 ↗
69. 10.1016/j.msec.2014.08.05410.1016/j.msec.2014.08.054 ↗
70. 10.1016/j.biomaterials.2016.10.00410.1016/j.biomaterials.2016.10.004 ↗
71. 10.1016/j.bioactmat.2017.05.00710.1016/j.bioactmat.2017.05.007 ↗
72. 10.1016/j.biomaterials.2006.07.03610.1016/j.biomaterials.2006.07.036 ↗
73. 10.1089/ten.2005.11.110.1089/ten.2005.11.1 ↗
74. 10.1038/nm.279310.1038/nm.2793 ↗
75. 10.1002/jcb.2307910.1002/jcb.23079 ↗